„”
Dr.
Endosomal chloride/proton exchangers need inhibitory TMEM9 β-subunits for regulation and prevention of disease-causing overactivity
Nature Communications 2025
read onlineStructural basis of ClC-3 transporter inhibition by TMEM9 and PtdIns(3,5)P2
Nature Structural & Molecular Biology 2025
read onlineCopper(II) import and reduction are dependent on His-Met clusters in the extracellular amino terminus of human copper transporter-1
Journal of Biological Chemistry 2022
read onlineCopper dependent ERK1/2 phosphorylation is essential for the viability of neurons and not glia
Metallomics 2022
read onlineToxicopathological impact of sub-lethal concentrations of lead nitrate on the gill of the catfish Heteropneustes fossilis
Acta Histochemica 2022
read onlineThe Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Rudower Chaussee 17
12489 Berlin, Germany